FUJIFILM Cellular Dynamics has officially opened its new headquarters and a cutting-edge induced pluripotent stem cell (iPSC) manufacturing facility in…
Read More
Pharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility
A notable surge in the acquisition of pharmaceutical manufacturing facilities by contract development and manufacturing organizations (CDMOs) has illuminated a…
Read More
Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure
Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…
Read More
Eli Lilly Pledges $4.5 Billion to Expand Indiana Manufacturing, Bolstering US Pharmaceutical Supply Chain
Eli Lilly and Company is significantly expanding its manufacturing footprint in Indiana with a substantial $4.5 billion investment, pushing its…
Read More
Creating early career opportunities for advanced therapy manufacturing and development
The RESILIENCE Skills program, a comprehensive UK-wide initiative, is actively addressing a critical talent deficit in advanced medicines manufacturing, a…
Read More
The Surge in Oncology Innovation Fuels Strategic Investment in HPAPI and ADC Manufacturing Capabilities
The accelerating demand for highly potent active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs) is compelling contract development and manufacturing…
Read More
Sartorius Unveils Groundbreaking Engineered CHO Cell Line Delivering Up to Three-Fold Productivity Boost for Biotherapeutic Manufacturing
Sartorius, a prominent international partner for life science research and the biopharmaceutical industry, has announced a significant breakthrough in biotherapeutic…
Read More
AbbVie Invests $1.4 Billion in North Carolina for New Manufacturing Hub
AbbVie, a global biopharmaceutical leader, has announced a landmark $1.4 billion investment to establish its first manufacturing facility in North…
Read More
US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance
The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…
Read More
US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs
The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…
Read MoreYOU MAY HAVE MISSED
